<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        452-212-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GLATIJECT
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GLATIRAMER
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Subcutaneous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        4110.40
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gland Pharma Limited " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gland Pharma Limited 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L03AX13 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Glatiject is a medicinal product which modifies the way in which your body&#39;s immune system works (it is classed as an immunomodulating agent). The symptoms of multiple sclerosis (MS) are thought to be caused by a defect in the body&#39;s immune system. This produces patches of inflammation in the brain and spinal cord.</p><p>Glatiject is used to reduce the number of times you suffer attacks of MS (relapses). It has not been demonstrated to help if you have any form of MS which does not have relapses, or hardly any relapses. Glatiject may not have any effect on the length of time an MS attack lasts, or how badly you suffer during an attack.</p><p>&nbsp;</p><p>It is used to treat patients who are able to walk without help.</p><p>&nbsp;</p><p>Glatiject may also be used in patients who have experienced symptoms for the first time which indicate a high risk of developing MS. Your doctor will rule out any other reasons which could explain these symptoms before you are treated.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Glatiject</strong></p><p>&nbsp;</p><p>if you are <strong>allergic to glatiramer acetate or any of the other ingredients</strong> of this medicine (listed in section 6).</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>Talk to your doctor or pharmacist before using Glatiject</p><p>&nbsp;</p><p>if you have any <strong>kidney or heart problems</strong> as you may need to have regular tests and check-ups.</p><p>&nbsp;</p><p><strong>Children</strong></p><p>&nbsp;</p><p>Glatiject is not to be used in children below the age of 12 years.</p><p>&nbsp;</p><p><strong>Elderly</strong></p><p>&nbsp;</p><p>Glatiject has not been specifically studied in the elderly. Please ask your doctor for advice.</p><p>&nbsp;</p><p><strong>Other medicines and Glatiject</strong></p><p>&nbsp;</p><p><strong>Tell your doctor or pharmacist </strong>if you are taking, have recently taken or might take any other<strong> </strong>medicines.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>&nbsp;</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice and consideration regarding Glatiject treatment during pregnancy and/or lactation.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>&nbsp;</p><p>Glatiject is not known to influence the ability to drive or operate machinery.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>The recommended daily dose in adults and adolescents aged 12 years and over is one pre-filled syringe (20 mg of glatiramer acetate), administered under the skin (subcutaneously).</p><p>&nbsp;</p><p>It is very important to inject Glatiject properly:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Into the tissue under the skin (subcutaneous tissue) only (see &quot;Instructions for Use&quot; below).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At the dose instructed by your doctor. Use only the dose prescribed by your doctor.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Never use the same syringe more than once. Any unused product or waste must be discarded.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not mix or co-administer the content of Glatiject pre-filled syringes with any product.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the solution contains particles, do not use it. Use a new syringe.</p><p>&nbsp;</p><p>The first time you use Glatiject you will be given full instructions and will be supervised by a doctor or nurse. They will be with you while you give yourself the injection and for half an hour afterwards, just to make sure you do not have any problems.</p><p>&nbsp;</p><p><strong>Instructions for use</strong></p><p>&nbsp;</p><p>Read these instructions carefully before using Glatiject.</p><p>Before the injection, make sure you have everything you need:</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; One blister with one Glatiject pre-filled syringe</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disposal unit for used needles and syringes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For each injection, take only one blister with one pre-filled syringe from the package. Keep all remaining syringes in the box</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your syringe has been stored in the refrigerator, take the blister containing the syringe out at least 20 minutes before you will inject the medicine so that it warms up to room temperature.</p><p>&nbsp;</p><p>Wash your hands thoroughly with soap and water.</p><p>&nbsp;</p><p>If you wish to use the Glatiject injection device to make your injection, please refer to the instructions for use provided with the Glatiject injection device.</p><p>&nbsp;</p><p>Choose the injection site, within the areas, using the diagrams.</p><p>There are seven possible areas on your body for injection:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Area 1: Stomach area (abdomen) around the belly button. Avoid 5 cm around the belly button,</p><p>&nbsp;</p><p><img alt="" width="148" height="145" src="data:image/png;base64,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" /></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Area 2 and 3: Thighs (above your knees),</p><p><img alt="" width="137" height="137" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Area 4, 5, 6 and 7: Back of the upper arms, and upper hips (below your waist).</p><p>&nbsp;</p><p><img alt="" width="292" height="137" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>Within each injection area there are several injection sites. Choose a different site for the injection every day. This will reduce the likeliness of any irritation or pain at the site of the injection. Rotate injection areas and also rotate the injection sites within an area. <strong>Do not use the same site each time.</strong></p><p>&nbsp;</p><p><strong>Please note: </strong>do not inject in any area that is painful or discoloured or where you feel firm knots or<strong> </strong>lumps.</p><p>&nbsp;</p><p>You should consider having a planned schedule for rotating injection sites and making a note of it in a diary. There are some sites on your body that may be difficult for self-injection (like the back of your arm). If you want to use these, you may require assistance.</p><p><strong>How to inject:&nbsp;&nbsp;&nbsp; </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the syringe from its protective blister by peeling back the blister lid.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the shield from the needle, do not remove the shield with your mouth or teeth.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gently pinch up the skin with the thumb and forefinger of the free hand (Figure 1).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Push the needle into the skin as shown in Figure 2.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject the medicine by steadily pushing the plunger all the way down until the syringe is empty.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the syringe and needle straight out.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Discard the syringe in a safe disposal container. Do not put used syringes into the household waste but dispose of them carefully in a puncture-proof container as recommended by your doctor or nurse.</p><p>&nbsp;</p><p><br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<img alt="" width="690" height="351" src="data:image/jpeg;base64,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" /></p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p><table cellpadding="0" cellspacing="0"><tbody><tr><td><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Figure 1&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Figure 2 &nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>If you have the impression that the effect of Glatiject is too strong or too weak, talk to your doctor.</p><p><strong>&nbsp;</strong></p><p><strong>If you use more Glatiject than you should</strong></p><p>&nbsp;</p><p>Talk to your doctor immediately.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to use Glatiject</strong></p><p>&nbsp;</p><p>Use it as soon as you remember but do not use a double dose to make up for forgotten individual doses. Use the next dose 24 hours later.</p><p>&nbsp;</p><p><strong>If you stop using Glatiject</strong></p><p>&nbsp;</p><p>Do not stop using Glatiject without consulting your doctor.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>Allergic reactions (hypersensitivity)</strong></p><p>&nbsp;</p><p>You may rarely develop a serious allergic reaction to this medicine.</p><p><strong>Stop using Glatiject and contact your doctor immediately or go to the casualty department at your nearest hospital, </strong>if you notice any sign of these side effects:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash (red spots or nettle rash)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of the eyelids, face or lips</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden shortness of breath</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Convulsions (fits)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Fainting.</p><p><strong>Other reactions following Injection (Immediate Post-Injection reaction)</strong></p><p>&nbsp;</p><p>It&rsquo;s uncommon, but some people may get one or more of the following symptoms within minutes after injecting Glatiject. They normally do not cause any problems and usually disappear within half an hour. However, if the following symptoms <strong>last longer than 30 minutes, contact your doctor immediately</strong> <strong>or go to the casualty department at your nearest hospital</strong>:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushing (reddening) of the chest or face (vasodilatation)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath (dyspnoea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chestpain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pounding and rapid heartbeat (palpitations, tachycardia).</p><p>In general the side effects reported by patients using Glatiject 40 mg/ml three times a week were also reported in patients who used Glatiject 20 mg/ml (see the following list).</p><p><strong>The following side effects have been reported with Glatiject: Very common </strong>side effects (may affect more than 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infections, flu</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anxiety, depression</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in the joints or back</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling weak, skin reactions at the injection site including reddening of skin, pain, formation of wheals, itching, tissue swelling, inflammation and hypersensitivity (these injection site reactions are not unusual and normally decrease over time), non-specific pain.</p><p><strong>Common </strong>side effects (may affect up to 1 in 10 people)</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the respiratory tract, gastric flu, cold sore, inflammation of the ears, runny nose, tooth abscess, vaginal thrush</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non-malignant skin growth (non-malignant neoplasm of skin), tissue growth (neoplasm)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lymph node swelling</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite, weight gain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; altered taste, increased tightness of muscle tone, migraine, speech disorder, fainting, tremor</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; double vision, eye disorder</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ear disorder</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough, hay fever</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disorder of anus or rectum, constipation, tooth decay, indigestion, difficulty in swallowing, bowel incontinence, vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal liver function test</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bruising, excessive sweating, itching, skin disorder, nettle rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; neck pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urge to empty your bladder, frequent urination, inability to empty your bladder appropriately</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chill, face swelling, wasting of tissue under the skin at injection site, local reaction, peripheral swelling due to build-up of fluid, fever</p><p>&nbsp;</p><p><strong>Uncommon </strong>side effects (may effect up to 1 in 100 people)</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abscess, inflammation of skin and the soft tissue underneath, boils, shingles, inflammation of kidney</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin cancer</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased white blood cell count, reduced white blood cell count, spleen enlargement, low blood platelet count, change in form of white blood cells</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; enlarged thyroid, overactive thyroid</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low alcohol tolerance, gout, increase in blood fat levels, increase in blood sodium, decrease in serum ferritin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal dreams, confusion, euphoric mood, seeing, hearing, smelling, tasting or feeling something that is not there (hallucinations), aggression, abnormal elevated mood, personality disorder, suicide attempt</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hand numbness and pain (carpal tunnel syndrome), mental disorder, fits (convulsion), problems with handwriting and reading, muscle disorders, problems with movement, muscle spasm, nerve inflammation, abnormal nerve-muscle link leading to abnormal muscle function, involuntary rapid movement of the eyeballs, paralysis, foot drop (peroneal nerve palsy), unconscious state (stupor), visual blind spots</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cataract, eye lesion in the cornea, dry eye, eye bleeding, droopy upper eyelid, pupil widening, wasting of the optic nerve leading to visual problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; extra heart beats, slow heart beats, episodic fast heart beats</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; varicose vein</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; periodic stops in breathing, nose bleeding, abnormally fast or deep breathing (hyperventilation), tight feeling in the throat, lung disorder, inability to breath due to throat tightness (choking sensation).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bowel inflammation, polyps in the colon, intestine inflammation, burping, ulcer in the gullet, inflammation of the gums, rectal bleeding, enlarged salivary glands</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gallstones, liver enlargement</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the skin and soft tissues, skin contact rash, painful red skin lumps, skin lumps</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, inflammation and pain of joints (arthritis or osteoarthritis), inflammation and pain of fluid-sacs lining the joint (exist in some of the joints), flank pain, decrease in the mass of muscles</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood in the urine, kidney stones, urinary tract disorder, urine abnormality</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abortion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; breast swelling, difficulties getting an erection, fall down or slip out of the place of pelvic organs (pelvic prolapse), sustained erections, disorders of prostate, abnormal PAP smear test (Smear Cervix Abnormal), testes disorder, vaginal bleeding, vaginal disorder</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cyst, hangover, low body temperature (hypothermia), non-specific inflammation, destruction of tissue at the injection site, problems with mucous membranes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disorders after vaccination</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Store in a refrigerator (2&deg;C &ndash; 8&deg;C).</p><p>Glatiject pre-filled syringes that have not been used and are still in their original packaging must be returned to the refrigerator.</p><p>Do not freeze.</p><p>Keep the pre-filled syringes in the outer carton in order to protect from light.</p><p>Do not use this medicine after the expiry date which is stated on the label and carton (EXP). The expiry date refers to the last day of that month.</p><p>Dispose of any syringes that contain particles.</p><p>Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is glatiramer acetate. 1 ml solution for injection (the contents of one pre-filled syringe) contains 20 mg glatiramer acetate.</p><p>&nbsp;</p><p>The other excipients are mannitol, Nitrogen NF and water for injections.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                A clear colorless to slightly yellow solution and free from visible particles in 1 ml pre-filled syringe
Pack size: 30 pre-filled syringes per Blister/Carton
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong><em>Manufactured By</em></strong></p><p><em>&nbsp;</em></p><p><em>Gland Pharma Limited </em></p><p><em>&nbsp;</em></p><p><strong><em>For</em></strong></p><p><em>&nbsp;</em></p><p><em>SPIMACO</em></p><p><em>&nbsp;</em></p><p><em>AlQassim pharmaceutical plant</em></p><p><em>&nbsp;</em></p><p><em>Saudi Pharmaceutical Industries &amp;</em></p><p><em>&nbsp;</em></p><p><em>Medical Appliance Corporation.</em></p><p><em>&nbsp;</em></p><p><em>Saudi Arabia</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                March 2019.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">جلاتيجكت هو دواء يعمل على تعديل الطريقة التي يعمل بها جهاز المناعة في الجسم (يتم تصنيفه على أنه&nbsp;دواء لتعديل المناعة).&nbsp;ويعتقد أن أعراض التصلب المتعدد (MS) تحدث&nbsp;بسبب خلل في جهاز المناعة في الجسم.&nbsp;يؤدي إلى ظهور بقع من&nbsp;الالتهاب في الدماغ والحبل الشوكي.</p><p dir="RTL">يستخدم جلاتيجكت&nbsp;لتقليل عدد المرات التي تعاني فيها من نوبات التصلب المتعدد MS&nbsp;(الانتكاسات).&nbsp;لم يثبت فاعليته إذا كان لديك أي شكل آخر من أشكال التصلب المتعدد التي&nbsp;لا يوجد بها انتكاسات، أو بالكاد تحدث انتكاسات.&nbsp;جلاتيجكت قد لا يكون له&nbsp;أي تأثير على طول الفترة الزمنية التي تستمر فيها الإصابة بمرض التصلب المتعدد، أو مدى معاناتك خلال&nbsp;الانتكاسة.&nbsp;</p><p dir="RTL">يتم استخدامه لعلاج المرضى القادرين على المشي دون مساعدة.</p><p dir="RTL">يمكن أيضًا استخدام جلاتيجكت في المرضى الذين عانوا من الأعراض للمرة الأولى والتي تشير إلى وجود مخاطر عالية للإصابة بمرض التصلب العصبي المتعدد. طبيبك سوف يستبعد أي أسباب أخرى يمكن أن تفسر هذه الأعراض قبل معالجتك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم</strong>&nbsp;<strong>جلاتيجكت</strong>&nbsp;</p><p dir="RTL">&bull;&nbsp;إذا كان&nbsp;لديك حساسية من&nbsp;جلاتيرامير&nbsp; أسيتات أو أي من المكونات الأخرى في هذا&nbsp;دواء (مدرج في القسم 6) ،</p><p dir="RTL"><strong>المحاذير والاحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل استخدام&nbsp;جلاتيجكت&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان&nbsp;لديك أي مشاكل في الكلى أو القلب حيث قد تحتاج إلى إجراء فحوصات منتظمة و&nbsp;تحاليل.</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لا يجب استخدام&nbsp;جلاتيجكت&nbsp;في الأطفال الذين تقل أعمارهم عن 12 عامًا.</p><p dir="RTL"><strong>كبار السن</strong></p><p dir="RTL">جلاتيجكت&nbsp;لم يتم اختباره على وجه التحديد مع كبار السن.&nbsp;من فضلك اطلب من طبيبك&nbsp;النصيحة.</p><p dir="RTL"><strong>الأدوية الأخرى و</strong>&nbsp;<strong>جلاتيجكت</strong>&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، تناولت مؤخرا أو قد تتناول أي&nbsp;أدوية أخرى.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنت حاملاً أو ترضعين رضاعة طبيعية ، تظنين أنك حامل أو تخططين لذلك&nbsp; ، اطلبي من طبيبك الحصول على المشورة والنظر فيما يتعلق&nbsp;ب جلاتيجكت&nbsp; أثناء الحمل و / أو الرضاعة.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">جلاتيجكت لا يعرف أن له تأثير على القدرة على القيادة أو تشغيل&nbsp;الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم هذا الدواء دائمًا كما أخبرك طبيبك المعالج.&nbsp;تحقق من خلال طبيبك المعالج&nbsp;أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL">الجرعة اليومية للبالغين والمراهقين الذين تبلغ أعمارهم 12 سنة وأكثر هي حقنة واحدة معبأة مسبقاً (20 ملجم من جلاتيرامير أسيتات)، تعطى تحت الجلد .</p><p dir="RTL">من المهم جداً حقن&nbsp;جلاتيجكت&nbsp; بشكل صحيح:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحقن في الأنسجة تحت الجلد فقط (انظر &quot;تعليمات الاستخدام&quot;&nbsp;أدناه).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة حسب تعليمات الطبيب.&nbsp;استخدم الجرعة التي يحددها الطبيب فقط.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻻ ﺗﺴﺘﺨﺪم ﻧﻔﺲ اﻟﻤﺤﻘﻨﺔ أكثر ﻣﻦ ﻣﺮة.&nbsp;يجب التخلص من أي حقنة أو بقايا غير مستخدمة&nbsp;.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻻ ﺗﺧﻟط أو&nbsp;تستخدم&nbsp;ﻣﺣﺗوى&nbsp;اﻟﻣﺣﺎﻗن المعبأة مسبقاً&nbsp;مع أي دواء أخر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان المحلول يحتوي على شوائب، فلا تستخدمه.&nbsp;استخدم حقنة جديدة.</p><p dir="RTL">في المرة الأولى التي تستخدم فيها&nbsp;جلاتيجكت سوف تحصل على التعليمات الكاملة وسيشرف عليها الطبيب أو الممرضة.&nbsp;سيبقون معك بينما تعطي نفسك&nbsp;الحقنة وبعدها بنصف ساعة، فقط للتأكد من عدم وجود أي مشاكل منها&nbsp;.</p><p dir="RTL"><strong>تعليمات الاستخدام</strong></p><p dir="RTL">يرجى قراءة هذه التعليمات بعناية قبل استخدام&nbsp;جلاتيجكت.</p><p dir="RTL">قبل الحقن، تأكد من حصولك على كل ما تحتاج إليه:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شريط واحد&nbsp;به&nbsp;حقنة معبأة مسبقاً</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وحدة التخلص من الإبر والحقن المستعملة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لكل حقنة، خذ شريط واحد فقط يحتوي على حقنة واحدة معبأة مسبقاً من&nbsp;العبوة.&nbsp;اترك جميع المحاقن المتبقية في العبوة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تم تخزين الحقنة في الثلاجة، اخرج الشريط المحتوي على&nbsp;الحقنة على الأقل 20 دقيقة خارج الثلاجة قبل أن يحقن الدواء حتى يصل إلى درجة حرارة الغرفة.</p><p dir="RTL">إغسل يديك بعناية بالصابون و الماء.</p><p dir="RTL">إذا كنت ترغب في استخدام&nbsp;جهاز حقن&nbsp;جلاتيجكت&nbsp;لإعطاء الحقن ، يرجى الرجوع&nbsp;إلى تعليمات الاستخدام المقدمة مع&nbsp;جهاز حقن&nbsp;جلاتيجكت&nbsp;.</p><p dir="RTL">اختيار مكان الحقن، فى حدود الأماكن المتاحة للحقن, وذلك باستخدام الرسوم التوضيحية.</p><p dir="RTL">هناك سبع مناطق في جسمك قابلة للحقن:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المنطقة 1: منطقة المعدة (البطن) حول السرة. مع تجنب 5 سم حول السرة.</p><p dir="RTL"><img alt="" width="148" height="145" src="data:image/png;base64,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" /></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المنطقتان 2 و 3: الأفخاذ (فوق ركبتيك),</p><p dir="RTL"><img alt="" width="137" height="137" src="data:image/png;base64,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" /></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المناطق 4 و 5 و 6 و 7: الجزء العلوى الخلفى من الذراعين والوركين (تحت الخصر).</p><p dir="RTL"><img alt="" width="292" height="137" src="data:image/png;base64,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" /></p><p dir="RTL">داخل كل منطقة حقن هناك العديد من أماكن الحقن.&nbsp;اختر&nbsp;مكان مختلف لكل حقنة.&nbsp;هذا سوف يقلل من احتمالية أي تهيج أو ألم&nbsp;في مكان الحقن.&nbsp;قم بتغيير أماكن الحقن داخل كل منطقة.&nbsp;<strong>لا تستخدم</strong>&nbsp;<strong>نفس المكان في كل مرة.</strong></p><p dir="RTL"><strong>يرجى ملاحظة:</strong>&nbsp;لا يحقن في أي منطقة مؤلمة أو&nbsp;تغير لونها&nbsp;أو في المكان الذي تشعر فيه&nbsp;بتكون عقد صلبة أو كتل.</p><p dir="RTL">يجب أن تضع في اعتبارك وجود جدول زمني مخطط لتغيير أماكن الحقن و&nbsp;تدوين هذا في اليوميات.&nbsp;هناك بعض الأماكن على جسمك قد تكون صعبة&nbsp;للحقن الذاتي (مثل الجزء الخلفي من ذراعك).&nbsp;إذا كنت ترغب في استخدام هذه الأماكن، قد تحتاج&nbsp;مساعدة.</p><p dir="RTL"><strong>كيفية الحقن:</strong></p><p dir="RTL">&bull; ﻗﻢ ﺑﺈزاﻟﺔ اﻟﻤﺤﻘﻨﺔ ﻣﻦ الشريط الواقي ﻋﻦ ﻃﺮﻳﻖ ﺗﻘﺸﻴﺮ اﻟﻐﻄﺎء.</p><p dir="RTL">&bull; أزل الدرع (الحماية) من الإبرة.</p><p dir="RTL">&bull; اقرص (ارفع) الجلد برفق باستخدام الإبهام والسبابة باليد الحرة (الشكل 1).</p><p dir="RTL">&bull; ادفع الإبرة في الجلد كما هو موضح في الشكل 2.</p><p dir="RTL">&bull; احقن الدواء عن طريق دفع المكبس باستمرار حتى&nbsp;تفرغ الحقنة.</p><p dir="RTL">&bull; اﺳﺣب اﻟﻣﺣﻘﻧﺔ واﻹﺑرة ﻣﺑﺎﺷرة.</p><p dir="RTL">&bull; تخلص من اﻟﻣﺣﻘﻧﺔ ﻓﻲ ﺣﺎوﯾﺔ اﻟﺗﺧﻟص اﻵﻣن.&nbsp;لا تضع المحاقن المستخدمة في&nbsp;النفايات المنزلية ولكن تخلص منها بعناية في حاوية مقاومة للثقب كما&nbsp;هو موصى به من قبل الطبيب أو الممرضة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><img alt="" width="690" height="351" src="data:image/jpeg;base64,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" /></p><p dir="RTL">الشكل 2&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; الشكل 1</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك إحساس أن تأثير&nbsp;جلاتيجكت قوي جدا أو ضعيف، تحدث مع طبيبك المعالج.</p><p dir="RTL"><strong>الجرعة الزائدة</strong></p><p dir="RTL">تحدث مع طبيبك على الفور.</p><p dir="RTL"><strong>إذا كنت قد نسيت استخدام</strong>&nbsp;<strong>جلاتيجكت</strong>&nbsp;</p><p dir="RTL">استخدمه بمجرد أن تتذكر ولكن لا تأخذ جرعة مضاعفة للتعويض عن الجرعات الفردية المنسية. خذ الجرعة التالية بعد 24 ساعة.</p><p dir="RTL">&nbsp;<strong>إذا توقفت عن استخدام</strong>&nbsp;<strong>جلاتيجكت</strong>&nbsp;</p><p dir="RTL">لا تتوقف عن استخدام&nbsp;جلاتيجكت دون استشارة الطبيب.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء ، اسأل طبيبك أو&nbsp;صيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية ، يمكن أن يسبب هذا الدواء أعراضا جانبية ، على الرغم من عدم تعرض الجميع لها.</p><p dir="RTL"><strong>ردود الفعل التحسسية (فرط الحساسية)</strong></p><p dir="RTL">يمكنك حدوث رد فعل تحسسي خطير لهذا الدواء ولكنها نادرة الحدوث.</p><p dir="RTL"><strong>توقف عن استخدام</strong>&nbsp;<strong>جلاتيجكت واتصل بالطبيب على الفور أو اذهب إلى</strong>&nbsp;<strong>أقرب قسم طوارئ في المستشفى</strong>&nbsp;<strong><em>،</em></strong>&nbsp;إذا لاحظت أي عرض من هذه الأعراض:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح&nbsp;(بقع حمراء أو طفح القراص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في الجفون أو الوجه أو الشفتين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق&nbsp;مفاجئ&nbsp;في التنفس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التشنجات&nbsp;(النوبات)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء</p><p dir="RTL"><strong>تفاعلات أخرى بعد الحقن (تفاعل ما بعد الحقن الفوري)</strong></p><p dir="RTL">أنها غير شائعة ولكن قد يتعرض بعض الأشخاص ل واحد أو أكثر من الأعراض التالية في غضون دقائق&nbsp;من حقن&nbsp;جلاتيجكت.&nbsp;عادة لا تسبب أي مشاكل وعادة&nbsp;تختفي في غضون نصف ساعة.</p><p dir="RTL">ومع ذلك، إذا استمرت الأعراض التالية&nbsp;<strong>لمدة أطول من 30 دقيقة، أخبر طبيبك</strong> <strong>على الفور</strong>&nbsp;<strong>أو قم بالذهاب إلى قسم الطوارئ في أقرب مستشفى:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار الصدر أو الوجه (توسع الأوعية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق&nbsp;في التنفس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في&nbsp;الصدر</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خفقان&nbsp;وسرعة ضربات القلب (الخفقان، عدم انتظام دقات القلب)</p><p dir="RTL"><strong>بشكل عام الأعراض الجانبية التي أبلغ عنها المرضى الذين يستخدمون</strong>&nbsp;<strong>جلاتيجكت</strong>&nbsp;<strong>40 ملجم / مل ثلاثة</strong>&nbsp;<strong> مرات في الأسبوع تم الإبلاغ عنها أيضا في المرضى الذين استخدموا</strong>&nbsp;<strong>جلاتيجكت</strong>&nbsp;<strong>20 ملجم / مل (انظر</strong>&nbsp;<strong>القائمة التالية).</strong></p><p dir="RTL"><strong>شائع جدا (قد يؤثر على أكثر من 1 من كل 10 أشخاص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العدوى&nbsp;، الانفلونزا</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القلق&nbsp;والاكتئاب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالمرض</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح&nbsp;الجلدي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم&nbsp;في المفاصل أو الظهر</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالضعف، ردود فعل للجلد في مكان الحقن بما في ذلك احمرار الجلد، والألم، &nbsp;توهج الجلد، حكة، تورم الأنسجة، التهاب وفرط حساسية&nbsp;(هذه التفاعلات في مكان الحقن ليست غير معتادة وعادة ما تنخفض بمرور الوقت)، &nbsp;ألم غير محدد</p><p dir="RTL"><strong>شائع &nbsp;(قد يؤثر على شخص واحد من كل 10 أشخاص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب&nbsp;في الجهاز التنفسي، أنفلونزا المعدة، قرحة البرد، التهاب الأذنين، سيلان&nbsp;الأنف، خراج الأسنان، القلاع المهبلية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نمو الجلد&nbsp;غير الخبيث&nbsp;(&nbsp;ورم&nbsp;الجلد غير الخبيث)، ونمو الأنسجة&nbsp;(ورم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم العقدة&nbsp;الليمفاوية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان&nbsp;الشهية، زيادة الوزن</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العصبية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيير المذاق، وزيادة شد العضلات، والصداع النصفي، واضطراب الكلام،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء&nbsp;، الهزة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف&nbsp;الرؤية، اضطراب العين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب&nbsp;الأذن</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السعال، حمى القش</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب&nbsp;فتحة الشرج أو المستقيم، والإمساك، وتسوس الأسنان، وعسر الهضم، وصعوبة في&nbsp;البلع، وسلس الأمعاء، والتقيؤ</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختبارات وظائف كبد&nbsp;غير طبيعية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كدمات ، تعرق مفرط ، حكة ، اضطراب جلدي ، طفح القراص</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام&nbsp;الرقبة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحاجة الملحة ل ﺗﻔﺮﻳﻎ المثانة واﻟﺘﺒﻮل اﻟﻤﺘﻜﺮر وﻋﺪم اﻟﻘﺪرة ﻋﻠﻰ ﺗﻔﺮﻳﻎ اﻟﻤﺜﺎﻧﺔ&nbsp;بشكل مناسب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البرد&nbsp;، تورم الوجه، تبدد الأنسجة تحت الجلد في مكان الحقن، رد فعل موضعي، &nbsp;تورم موضعي بسبب تراكم السوائل والحمى</p><p dir="RTL"><strong>غير شائع (قد يؤثر على شخص واحد من بين كل 100 شخص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخراج&nbsp;والتهاب الجلد والأنسجة الرخوة تحتها ، الدمامل ، القوباء المنطقية ،&nbsp;التهاب الكلى</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سرطان&nbsp;الجلد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة&nbsp;عدد خلايا الدم البيضاء، وانخفاض عدد خلايا الدم البيضاء وتضخم الطحال&nbsp;، انخفاض عدد الصفائح الدموية، وتغير في شكل خلايا الدم البيضاء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضخم&nbsp;الغدة الدرقية ، فرط نشاط الغدة الدرقية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض&nbsp;تحمل الكحول ، والنقرس ، وزيادة مستويات الدهون في الدم ، وزيادة في الصوديوم في الدم ،&nbsp;انخفاض في&nbsp;نسبة الفيريتين في الدم&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأحلام&nbsp;الغريبة&nbsp;، والارتباك، الإحساس بالبهجة الغير طبيعية، رؤية، سمع، شم، أو تذوق أو&nbsp;شعور بشيء غير موجود (الهلوسة)، العدوان، مزاج جيد غير طبيعي، اضطراب الشخصية، محاولة الانتحار</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خدر اليد والألم (متلازمة النفق الرسغي) ، اضطراب عقلي ، نوبات&nbsp;(التشنجات) ، مشاكل في الكتابة اليدوية ، اضطرابات العضلات ، مشاكل&nbsp;مع الحركة ، وتشنج العضلات ، والتهاب الأعصاب ، اتصال العصب العضلي غير طبيعي&nbsp;مما يؤدي إلى وظيفة عضلية غير طبيعية ، وحركة سريعة لاإرادية في مقل العيون ،&nbsp;شلل ، سقوط القدم (&nbsp;شلل العصب&nbsp;الشظوي&nbsp;) ، حالة غير واعية (ذهول) ، بقع بصرية عمياء&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الساد&nbsp;(إعتام عدسة العين)، خلل العين في القرنية ، جفاف العين ، نزيف العين ، &nbsp;سقوط الجفن العلوي ، اتساع الحدقة&nbsp; ، تلف العصب البصري مما يؤدي إلى مشاكل بصرية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull;&nbsp;دقات القلب&nbsp;زائدة، &nbsp;وبطء ضربات القلب، &nbsp; دقات القلب السريعة العرضية&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوالي&nbsp;الأوردة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; توقف&nbsp;دوري&nbsp;في التنفس، نزيف الأنف، تنفس سريع أو عميق بشكل غير طبيعي&nbsp;(فرط التنفس)، شعور بضيق في الحلق، اضطراب في الرئة، عدم القدرة على التنفس بسبب&nbsp;ضيق الحلق (إحساس الاختناق)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب&nbsp;الأمعاء&nbsp;، الأورام الحميدة في القولون، التهاب الأمعاء، التجشؤ، القرحة في&nbsp;المريء، التهاب اللثة، نزيف المستقيم، الغدد اللعابية المتضخمة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حصى في المرارة&nbsp;وتضخم الكبد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في الجلد والأنسجة الرخوة، طفح جلدي تلامسي، كتل جلد حمراء مؤلمة، كتل جلدية&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التورم&nbsp;والالتهاب وألم المفاصل (التهاب المفاصل أو هشاشة العظام) ، والتهاب&nbsp;وألم حويصلات السوائل التي تربط المفصل (توجد في بعض المفاصل) ، ألم في الخاصرة ،&nbsp;انخفاض في كتلة العضلات</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدم&nbsp;في البول، حصى الكلى، اضطراب المسالك البولية، تغيرات في البول</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإجهاض</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الثدي أو صعوبة في الانتصاب أو سقوط أو انزلاق أعضاء الحوض من مكانها&nbsp; (&nbsp;هبوط&nbsp;الحوض&nbsp;) ، الانتصاب المستمر ، اضطرابات البروستاتا ،&nbsp; اختبار مسحة PAP غير طبيعي (مسحة عنق الرحم غير طبيعي) ، اضطرابات الخصية ، نزيف مهبلي&nbsp; ، اضطراب مهبلي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تكييسات&nbsp;، دوار ، انخفاض درجة حرارة الجسم (انخفاض درجة الحرارة) ، التهاب غير محدد ،&nbsp;تلف الأنسجة في مكان الحقن ، مشاكل في الأغشية المخاطية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاضطرابات&nbsp;بعد التطعيم</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا تعرضت لأي أعراض جانبية، تحدث إلى طبيبك أو الصيدلي.&nbsp;وهذا يشمل أي أعراض جانبية&nbsp;محتملة&nbsp;غير المدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هذا الدواء بعيدا عن متناول ونظر الأطفال.</p><p dir="RTL">يحفظ في الثلاجة (2 درجة مئوية - 8 درجة مئوية).</p><p dir="RTL">محاقن جلاتيجكت المعبأة مسبقا التي لم يتم استخدامها والتي لا تزال في عبوتها الأصلية يجب إعادتها إلى الثلاجة.</p><p dir="RTL">لا تقم بتجميدها.</p><p dir="RTL">أحفظ الحقن المعبأة مسبقًا في الكرتون الخارجي من أجل الحماية من الضوء.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على الملصق والكرتون&nbsp;(EXP).&nbsp;يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">تخلص من أي محاقن تحتوي على شوائب.</p><p dir="RTL">لا تتخلص من أي دواء عن طريق مياه الصرف الصحي أو النفايات المنزلية.&nbsp;اسأل&nbsp;الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها.&nbsp;هذه التدابير سوف&nbsp;تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما</strong>&nbsp;هو <strong>جلاتيجكت وعلى ماذا يحتوي </strong></p><p dir="RTL">&bull; المادة الفعالة هي&nbsp;جلاتيرامير&nbsp;أسيتات.&nbsp;1 مل من محلول الحقن (حقنة واحدة معبأة مسبقا) تحتوي على 20 ملجم&nbsp;جلاتيرامير&nbsp; أسيتات&nbsp;.</p><p dir="RTL">&bull; المكونات الأخرى هي&nbsp;المانيتول،&nbsp;النيتروجين والماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">محلول صافي عديم اللون إلى أصفر قليلا وخالي من الشوائب المرئية&nbsp;في 1 مل&nbsp;حقنة معبأة مسبقا</p><p dir="RTL">حجم العبوة: 30 حقنة معبأة مسبقا لكل شريط لكل كرتونه</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;<em>صنع بواسطة</em></strong></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>جلاند</em>&nbsp;<em>فارما</em>&nbsp;<em>المحدودة</em></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong><em>لصالح</em></strong></p><p dir="RTL"><em>&nbsp;&nbsp;</em></p><p dir="RTL">الدوائية</p><p dir="RTL">مصنع الأدوية بالقصيم،</p><p dir="RTL">الشركة السعودية للصناعات الدوائية والمستلزمات الطبية،</p><p dir="RTL">المملكة العربية السعودية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مارس 2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glatiject ® 20 mg/ml Solution for Injection, Pre-filled Syringe

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 ml of solution for injection contains 20 mg glatiramer acetate
For full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for Injection, Pre-filled Syringe
A clear colorless to slightly yellow solution and free from visible particles 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glatiject is indicated for the treatment of relapsing forms of multiple sclerosis (MS) (see section 5.1 for important information on the population for which efficacy has been established). Glatiject is not indicated in primary or secondary progressive MS..</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The initiation of Glatiject treatment should be supervised by a neurologist or a physician experienced in the treatment of MS.</p><p><strong>Posology </strong></p><p>The recommended dosage in adults is 20 mg of glatiramer acetate (one pre-filled syringe), administered as a subcutaneous injection once daily. At the present time, it is not known for how long the patient should be treated. A decision concerning long term treatment should be made on an individual basis by the treating physician.</p><p>Renal impairment</p><p>Glatiject has not been specifically studied in patients with renal impairment (see section 4.4). Elderly Glatiject has not been specifically studied in the elderly.</p><p>Paediatric population</p><p>The safety and efficacy of glatiramer acetate in children and adolescents has not been established. However, limited published data suggest that the safety profile in adolescents from 12 to 18 years of age receiving Glatiject 20 mg subcutaneously every day is similar to that seen in adults. There is not enough information available on the use of Glatiject in children below 12 years of age to make any recommendation for its use. Therefore, Glatiject should not be used in this population.</p><p><u>Method of administration</u></p><p>Glatiject is for subcutaneous use. Patients should be instructed in self-injection techniques and should be supervised by a health-care professional the first time they self-inject and for 30 minutes after. A different site should be chosen for every injection, so this will reduce the chances of any irritation or pain at the site of the injection. Sites for self-injection include the abdomen, arms, hips and thighs. The CSYNC device is available should the patients want to make their injection with an injection device. The CSYNC device is an autoinjector to be used with Glatiject pre-filled syringes and it has not been tested with other pre-filled syringes. The CSYNC device should be used as recommended in the information provided by the device manufacturer.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glatiject is contraindicated under the following conditions:
• Hypersensitivity to glatiramer acetate or mannitol
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glatiject should only be administered subcutaneously. Glatiject should not be administered by intravenous or intramuscular routes. The initiation of Glatiject treatment should be supervised by a neurologist or a physician experienced in the treatment of MS. The treating physician should explain to the patient that a reaction associated with at least one of the following symptoms may occur within minutes of a Glatiject injection: vasodilatation (flushing), chest pain, dyspnoea, palpitations or tachycardia. The majority of these symptoms is short-lived and resolves spontaneously without any sequelae. Should a severe adverse event occur, the patient must immediately stop Glatiject treatment and contact his/her physician or any emergency doctor. Symptomatic treatment may be instituted at the discretion of the physician. There is no evidence to suggest that any particular patient groups are at special risk from these reactions. Nevertheless, caution should be exercised when administering Glatiject to patients with pre-existing cardiac disorders. These patients should be followed up regularly during treatment. Convulsions and/or anaphylactoid or allergic reactions have been reported rarely. Serious hypersensitivity reactions (e.g. bronchospasm, anaphylaxis or urticaria) may rarely occur. If reactions are severe, appropriate treatment should be instituted and Glatiject should be discontinued. Glatiramer acetate-reactive antibodies were detected in patients&#39; sera during daily chronic treatment with Glatiject. Maximal levels were attained after average treatment duration of 3-4 months and, thereafter, declined and stabilised at a level slightly higher than baseline. There is no evidence to suggest that these glatiramer acetate-reactive antibodies are neutralising or that their formation is likely to affect the clinical efficacy of Glatiject.&nbsp;</p><p>In patients with renal impairment, renal function should be monitored while they are treated with Glatiject. Whilst there is no evidence of glomerular deposition of immune complexes in patients, the possibility cannot be excluded.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interaction between Glatiject and other medicinal products have not been formally evaluated. Observations from existing clinical trials and post-marketing experience do not suggest any significant interactions of Glatiject with therapies commonly used in MS patients, including the concurrent use of corticosteroids for up to 28 days. In vitro work suggests that glatiramer acetate in blood is highly bound to plasma proteins but that it is not displaced by, and does not itself displace, phenytoin or carbamazepine. Nevertheless, as Glatiject has, theoretically, the potential to affect the distribution of protein bound substances, concomitant use of such medicinal products should be monitored carefully.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Studies in animals have not shown reproductive toxicity (see section 5.3). Current data on pregnant women indicate no malformative or feto/neonatal toxicity of Glatiject. To date, no relevant epidemiological data are available. As a precautionary measure, it is preferable to avoid the use of Glatiject during pregnancy unless the benefit to the mother outweighs the risk to the foetus.</p><p><u>Breastfeeding</u></p><p>It is unknown whether glatiramer acetate or its metabolites are excreted in human milk. In rats, no significant effects on offspring were observed except for a slight reduction in body weight gains in the offspring of mothers dosed during pregnancy and throughout lactation (see section 5.3).</p><p>A risk to the newborns/infants cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Glatiject therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In all clinical trials, injection-site reactions were seen to be the most frequent adverse reactions and were reported by the majority of patients receiving Glatiject. In controlled studies, the proportion of patients reporting these reactions, at least once, was higher following treatment with Glatiject (70%) than placebo injections (37%). The most commonly reported injection-site reactions, in clinical trials and in post marketing experience, were erythema, pain, mass, pruritus, oedema, inflammation and hypersensitivity, and rare occurrences of lipoatrophy and skin necrosis. A reaction, associated with at least one or more of the following symptoms, has been described as the Immediate Post-Injection Reaction: vasodilatation(flushing), chest pain,&nbsp;dyspnoea, palpitation or tachycardia. This reaction may occur within minutes of a Glatiject injection. At least one component of this Immediate Post-Injection Reaction was reported at least once by 31% of patients receiving Glatiject compared to 13% of patients receiving placebo. All adverse reactions, which were more frequently reported in Glatiject vs. placebo-treated patients, are presented in the table below. This data was derived from four pivotal, doubleblind, placebo-controlled clinical trials with a total of 512 patients treated with Glatiject and 509 patients treated with placebo for up to 36 months. Three trials in relapsingremitting MS (RRMS) included a total of 269 patients treated with Glatiject and 271 patients treated with placebo for up to 35 months. The fourth trial in patients who have experienced a first clinical episode and were determined to be at high risk of developing clinically definite MS included 243 patients treated with Glatiject and 238 patients treated with placebo for up to 36 months.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:674px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class (SOC)</strong></p></td><td style="vertical-align:top"><p><strong>Very Common (&ge;1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Common (&ge;1/100 to &lt;1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon (&ge;1/1,000 to &lt;1/100)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Infection, Influenza</p></td><td style="vertical-align:top"><p>Bronchitis, Gastroenteritis, Herpes Simplex, Otitis Media, Rhinitis, Tooth Abscess, Vaginal Candidiasis*</p></td><td style="vertical-align:top"><p>Abscess, Cellulitis, Furuncle, Herpes Zoster, Pyelonephritis</p></td></tr><tr><td style="vertical-align:top"><p>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Benign Neoplasm Of Skin, Neoplasm</p></td><td style="vertical-align:top"><p>Skin Cancer</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Lymphadenopathy*</p></td><td style="vertical-align:top"><p>Leukocytosis, Leukopenia, Splenomegaly Thrombocytopenia, Lymphocyte Morphology Abnormal</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Hypersensitivity</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Goitre, Hyperthyroidism</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Anorexia, Weight Increased*</p></td><td style="vertical-align:top"><p>Alcohol Intolerance, Gout, Hyperlipidaemia, Blood Sodium Increased, Serum Ferritin Decreased</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Anxiety*, Depression</p></td><td style="vertical-align:top"><p>Nervousness</p></td><td style="vertical-align:top"><p>Abnormal Dreams, Confusional State, Euphoric Mood, Hallucination, Hostility, Mania, Personality Disorder, Suicide Attempt</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Headache,</p></td><td style="vertical-align:top"><p>Dysgeusia, Hypertonia, Migraine, Speech Disorder, Syncope, Tremor*</p></td><td style="vertical-align:top"><p>Carpal Tunnel Syndrome, Cognitive Disorder, Convulsion, Dysgraphia, Dyslexia, Dystonia, Motor Dysfunction, Myoclonus, Neuritis, Neuromuscular Blockade, Nystagmus, Paralysis, Peroneal Nerve Palsy, Stupor, Visual Field Defect</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Diplopia, Eye Disorder*</p></td><td style="vertical-align:top"><p>Cataract, Corneal Lesion, Dry Eye, Eye Haemorrhage, Eyelid Ptosis, Mydriasis, Optic Atrophy</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Ear Disorder</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Palpitations*, Tachycardia*</p></td><td style="vertical-align:top"><p>Extrasystoles, Sinus Bradycardia, Tachycardia Paroxysmal</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Vasodilatation*</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Varicose Vein</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Dyspnoea*</p></td><td style="vertical-align:top"><p>Cough, Rhinitis Seasonal</p></td><td style="vertical-align:top"><p>Apnoea, Epistaxis, Hyperventilation, Laryngospasm, Lung Disorder, Choking Sensation</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Nausea*</p></td><td style="vertical-align:top"><p>Anorectal Disorder, Constipation, Dental Caries, Dyspepsia, Dysphagia, Faecal Incontinence, Vomiting*</p></td><td style="vertical-align:top"><p>Colitis, Colonic Polyp, Enterocolitis, Eructation, Oesophageal Ulcer, Periodontitis Rectal Haemorrhage, Salivary Gland Enlargement</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Liver Function Test Abnormal</p></td><td style="vertical-align:top"><p>Cholelithiasis, Hepatomegaly</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Rash*</p></td><td style="vertical-align:top"><p>Ecchymosis, Hyperhidrosis, Pruritus, Skin Disorder*, Urticaria</p></td><td style="vertical-align:top"><p>Angioedema, Dermatitis Contact, Erythema Nodosum, Skin Nodule</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Arthralgia, Back Pain*</p></td><td style="vertical-align:top"><p>Neck Pain</p></td><td style="vertical-align:top"><p>Arthritis, Bursitis, Flank Pain, Muscle Atrophy, Osteoarthritis</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Micturition Urgency, Pollakiuria, Urinary Retention</p></td><td style="vertical-align:top"><p>Haematuria, Nephrolithiasis, Urinary Tract Disorder, Urine Abnormality</p></td></tr><tr><td style="vertical-align:top"><p>Pregnancy, puerperium and perinatal Conditions</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Abortion</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Breast Engorgement, Erectile Dysfunction, Pelvic Prolapse, Priapism, Prostatic Disorder, Smear Cervix Abnormal, Testicular Disorder, Vaginal Haemorrhage, Vulvovaginal Disorder</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Asthenia, Chest Pain*, Injection Site Reactions*&sect;, Pain*</p></td><td style="vertical-align:top"><p>Chills*, Face Oedema*, Injection Site Atrophy<sup>&clubs;</sup>, Local Reaction*, Oedema Peripheral, Oedema, Pyrexia</p></td><td style="vertical-align:top"><p>Cyst, Hangover, Hypothermia, Immediate Post-Injection Reaction, Inflammation, Injection Site Necrosis, Mucous Membrane Disorder</p></td></tr><tr><td style="vertical-align:top"><p>Injury, poisoning and procedural complications</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Post Vaccination Syndrome</p></td></tr></tbody></table><p>&nbsp;</p><p>* More than 2% (&gt;2/100) higher incidence in the Glatiject treatment group than in the placebo group. Adverse reaction without the * symbol represents a difference of less than or equal to 2%.</p><p>&sect; The term &#39;Injection site reactions&#39; (various kinds) comprises all adverse events occurring at the injection site excluding injection site atrophy and injection site necrosis, which are presented separately within the table.</p><p>&clubs; Includes terms which relate to localized lipoatrophy at the injection sites<strong>.</strong></p><p>In the fourth trial noted above, an open-label treatment phase followed the placebo-controlled period (see section 5.1). No change in the known risk profile of Glatiject was observed during the open-label follow-up period of up to 5 years.</p><p><u>The following adverse reaction reports were collected from MS patients treated with Glatiject in uncontrolled clinical trials and from post-marketing experience with Glatiject: hypersensitivity reactions (including rare occurrence of anaphylaxis, &gt;1/10000, &lt; 1/1000.</u></p><p><u>&nbsp;</u></p><p>To report any side effect(s):</p><p>&bull; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>Fax: +966-11-205-7662 Call NPC at: +966-11-2038222 Exts: 2317-2356-2340.</p><p>Hotline: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A few cases of overdose with Glatiject (up to 300 mg glatiramer acetate) have been reported. These cases were not associated with any adverse reactions other than those mentioned in section 4.8. In case of overdose, patients should be monitored and the appropriate symptomatic and supportive therapy instituted.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antineoplastic and immunomodulating agents, other immunostimulants</p><p>ATC code: L03AX13</p><p><u>Mechanism of action</u></p><p>The mechanism by which glatiramer acetate exerts therapeutic effects in relapsing forms of MS is not fully elucidated but is presumed to involve modulation of immune processes. Studies in animals and MS patients suggest glatiramer acetate acts on innate immune cells, including monocytes, dendritic cells and B cells, which in turn modulate adaptive functions of B and T cells inducing anti-inflammatory and regulatory cytokine secretion. Whether the therapeutic effect is mediated by the cellular effects described above is not known because the pathophysiology of MS is only partially understood</p><p><u>Clinical efficacy and safety</u></p><p>RRMS:</p><p>A total of 269 patients have been treated with Glatiject in three controlled trials. The first was a two-year study involving 50 patients (Glatiject n=25, placebo n=25) who were diagnosed with relapsing-remitting MS by the then-applicable standard criteria, and who had at least two attacks of neurological dysfunction (exacerbations) during the preceding two years. The second study applied the same inclusion criteria and included 251 patients treated for up to 35 months (Glatiject n=125, placebo n=126). The third study was a ninemonth study involving 239 patients (Glatiject n=119, placebo n=120) where inclusion criteria were similar to those in the first and second studies with the additional criterion that patients had to have at least one gadolinium-enhancing lesion on the screening MRI.</p><p>In clinical trials in MS patients receiving Glatiject, a significant reduction in the number of relapses, compared with placebo, was seen.&nbsp;</p><p>In the largest controlled study, the relapse rate was reduced by 32% from 1.98 under placebo to 1.34 under glatiramer acetate. Exposure data are available for up to twelve years in 103 patients treated with Glatiject. Glatiject has also demonstrated beneficial effects over placebo on MRI parameters relevant to relapsing-remitting MS. Glatiject 20 mg/mL: In the controlled study 9001/9001E, which enrolled 251 patients, who were followed for up to 35 months (including a blinded phase extension 9001E of the 9001 study), the cumulative percentage of patients who developed 3-month confirmed disability progression was 29.4% for placebo and 23.2% for Glatiject-treated patients (p=0.199). There is no evidence that Glatiject treatment has an effect on relapse duration or severity. There is currently no evidence for the use of Glatiject in patients with primary or secondary progressive disease. Single clinical event suggestive of MS: One placebo-controlled study involving 481 patients (Glatiject n=243, placebo n=238) was performed in patients with a well-defined, single, unifocal neurological manifestation and MRI features highly suggestive of MS (at least two cerebral lesions on the T2-weighted MRI above 6 mm diameter). Any disease other than MS that could better explain signs and symptoms of the patient had to be excluded. The placebo-controlled period was followed by an open label treatment: Patients who either presented with MS symptoms or were asymptomatic for three years, whichever came first, were assigned to active drug treatment in an open-label phase for an additional period of two years, not exceeding a maximal total treatment duration of 5 years. Of the 243 patients initially randomised to Glatiject, 198 continued Glatiject treatment in the open-label phase. Of the 238 patients initially randomised to placebo, 211 switched to Glatiject treatment in the open-label phase.</p><p>During the placebo-controlled period of up to three years, Glatiject delayed the progression from the first clinical event to clinically definite multiple sclerosis (CDMS) according to Poser criteria in a statistically significant and clinically meaningful manner, corresponding to a risk reduction of 45% (Hazard Ratio = 0.55; 95% CI [0.40; 0.77], p-value=0.0005). The proportion of patients who converted to CDMS was 43% for the placebo group and 25% in the Glatiject group.</p><p>The favourable effect of treatment with Glatiject over placebo was also demonstrated in two secondary MRI endpoints, i.e. number of new T2 lesions and T2 lesion volume.</p><p>Post-hoc subgroup analyses were performed in patients with various baseline characteristics to identify a population at high risk to develop the second attack. For subjects with baseline MRI with at least one T1 Gd-enhancing lesion and 9 or more T2 lesions, conversion to CDMS was evident for 50% of the placebo subjects vs. 28% of the Glatiject subjects in 2.4 years. For subjects with 9 or more T2 lesions at baseline, conversion to CDMS was evident for 45% of the placebo subjects vs. 26% on Glatiject in 2.4 years. However, the impact of early treatment with Glatiject on the long term evolution of the disease is unknown even in these high-risk subgroups as the study was mainly designed to assess the time to the second event. In any case, treatment should only be considered for patients classified at high risk. The effect shown in the placebo-controlled phase was sustained in the long-term followup period of up to 5 years. The time progression from the first clinical event to CDMS was prolonged with earlier Glatiject treatment as compared to delayed treatment, reflecting a 41% risk reduction with earlier versus later treatment (Hazard Ratio = 0.59; 95% CI [0.44; 0.80], p-value=0.0005). The proportion of subjects in the Delayed Start group who progressed was higher (49.6%) compared to those in the Early Start group (32.9%). A consistent effect in favour of early treatment over delayed treatment across time was shown for the annualised number of lesions over the entire study period in new T1 Gdenhancing lesions (reduced by 54%; p&lt;0.0001), new T2 lesions (reduced by 42%; p&lt;0.0001) and new T1 hypointense lesions (reduced by 52%; p&lt;0.0001). An effect in reductions in favour of early versus delayed treatment was also observed for the total number of new T1 Gd-enhancing lesions (reduced by 46%; p=0.001), T1 Gd-enhancing lesion volume (a mean difference of -0.06 ml; p&lt;0.001), as well as the total number of new T1 hypointense lesions (reduced by 46%; p&lt;0.001) measured over the entire study period. No appreciable differences between the Early Start and Delayed Start cohorts were observed for either hypointense T1 lesion volume or brain atrophy over 5 years. However, analysis of brain atrophy at last observed value (adjusted to treatment exposure) showed a reduction in favour of early treatment with GA (the mean difference of percent change in brain volume was 0.28%; p=0.0209).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacokinetic studies in patients have not been performed. In vitro data and limited data from healthy volunteers indicate that with subcutaneous administration of glatiramer acetate, the active substance is readily absorbed and that a large part of the dose is rapidly degraded to smaller fragments already in subcutaneous tissue.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on studies of safety pharmacology, repeated dose toxicity, toxicity to reproduction, genotoxicity or carcinogenicity, beyond the information included in other sections of the SPC. Due to the lack of pharmacokinetic data in humans, margins of exposure between humans and animals can not be established. Immune complex deposition in the glomeruli of the kidney was reported in a small number of rats and monkeys treated for at least 6 months. In a 2 years rat study, no indication of immune complex deposition in the glomeruli of the kidney was seen. Anaphylaxis after administration to sensitised animals (guinea pigs or mice) was reported. The relevance of these data for humans is unknown. Toxicity at the injection site was a common finding after repeated administration in animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glatiramer acetate</p><p>Mannitol USP (Pyrogen Free Grade)</p><p>Water for injection USP</p><p>Nitrogen NF</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Keep the pre-filled syringes in the outer carton, in order to protect from light.</p><p>&bull; Store in a refrigerator (2&deg;C - 8&deg;C)</p><p>&bull; Do not freeze</p><p>&bull; Keep the container in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1ml Prefilled syringe</p><p>Pack Size: 30 PFS per Blister/Carton</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For single use only. Any unused product or waste material must be discarded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured By
Gland Pharma Limited
For
SPIMACO
AlQassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation.
Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2019.

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>